Dr. Vince Case Studies
-
Strategic Implications Of The Single Phase 3 Approval Paradigm
7/21/2026
As FDA single-trial approvals gain traction, CNS developers need stronger early evidence. Learn how biomarkers, patient selection, and regulatory strategy can accelerate development.